Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness

Leonid Yurkovetskiy, Shawn Egri, Chaitanya Kurhade, Marco A. Diaz-Salinas, Javier A. Jaimes, Thomas Nyalile, View ORCID ProfileXuping Xie, Manish C. Choudhary, Ann Dauphin, Jonathan Z. Li, View ORCID ProfileJames B. Munro, Pei-Yong Shi, Kuang Shen, View ORCID ProfileJeremy Luban
doi: https://doi.org/10.1101/2023.03.30.535005
Leonid Yurkovetskiy
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
2Massachusetts Consortium on Pathogen Readiness, Boston, MA, 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shawn Egri
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chaitanya Kurhade
3Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco A. Diaz-Salinas
4Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier A. Jaimes
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
2Massachusetts Consortium on Pathogen Readiness, Boston, MA, 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Nyalile
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
2Massachusetts Consortium on Pathogen Readiness, Boston, MA, 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuping Xie
3Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xuping Xie
Manish C. Choudhary
2Massachusetts Consortium on Pathogen Readiness, Boston, MA, 02115
5Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Dauphin
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
2Massachusetts Consortium on Pathogen Readiness, Boston, MA, 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Z. Li
2Massachusetts Consortium on Pathogen Readiness, Boston, MA, 02115
5Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James B. Munro
4Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605, USA
6Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, MA 01605, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James B. Munro
Pei-Yong Shi
3Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuang Shen
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
2Massachusetts Consortium on Pathogen Readiness, Boston, MA, 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy Luban
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
2Massachusetts Consortium on Pathogen Readiness, Boston, MA, 02115
6Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, MA 01605, USA
7Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA
8Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeremy Luban
  • For correspondence: jeremy.luban@umassmed.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract/Summary

SARS-CoV-2 variants bearing complex combinations of mutations have been associated with increased transmissibility, COVID-19 severity, and immune escape. S:D614G may have facilitated emergence of such variants since they appeared after S:D614G had gone to fixation. To test this hypothesis, Spike sequences from an immunocompromised individual with prolonged infection, and from the major SARS-CoV-2 variants of concern, were reverted to the ancestral S:D614. In all cases, infectivity of the revertants was compromised. Rare SARS-CoV-2 lineages that lack S:D614G were identified and the infectivity of these was dependent upon S:Q613H or S:H655Y. Notably, Gamma and Omicron variants possess both S:D614G and S:H655Y, each of which contributed to infectivity of these variants. All three mutations, S:Q613H, S:D614G, and S:H655Y, stabilized Spike on virions, consistent with selection of these mutations by a common molecular mechanism. Among sarbecoviruses, S:Q613H, S:D614G, and S:H655Y are only detected in SARS-CoV-2, which uniquely possesses a polybasic S1/S2 cleavage site. Results of genetic and biochemical experiments here demonstrated that S:D614G and S:H655Y are likely adaptations to the cleavage site. CryoEM revealed that both mutations shift the Spike receptor binding domain towards the open conformation required for ACE2-binding and Spikes bearing either S:D614G or S:H655Y spontaneously mimic the smFRET signal that ACE2 induces in the parental molecule. Data from these orthogonal experiments demonstrate that S:D614G and S:H655Y are convergent adaptations to the polybasic S1/S2 cleavage site, which stabilize S1 on the virion in the open RBD conformation that is on-pathway for target cell fusion, and thereby act epistatically to promote the fitness of variants bearing complex combinations of clinically significant mutations.

Figure
  • Download figure
  • Open in new tab

Highlights

  • S:D614G is ubiquitous among SARS-CoV-2 B-lineage Spikes and is required for infectivity of the main Variants of Concern

  • In an example of convergent evolution, rare SARS-CoV-2 A lineage viruses maintained transmission chains in the absence of S:D614G, but were instead dependent upon S:Q613H or S:H655Y

  • S:D614G and S:H655Y are both adaptations to the polybasic S1/S2 cleavage site

  • Increased infectivity of S:D614G and S:H655Y is associated with a more open RBD conformation and increased steady-state levels of virion-associated S1

Competing Interest Statement

The authors have declared no competing interest.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 31, 2023.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness
Leonid Yurkovetskiy, Shawn Egri, Chaitanya Kurhade, Marco A. Diaz-Salinas, Javier A. Jaimes, Thomas Nyalile, Xuping Xie, Manish C. Choudhary, Ann Dauphin, Jonathan Z. Li, James B. Munro, Pei-Yong Shi, Kuang Shen, Jeremy Luban
bioRxiv 2023.03.30.535005; doi: https://doi.org/10.1101/2023.03.30.535005
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness
Leonid Yurkovetskiy, Shawn Egri, Chaitanya Kurhade, Marco A. Diaz-Salinas, Javier A. Jaimes, Thomas Nyalile, Xuping Xie, Manish C. Choudhary, Ann Dauphin, Jonathan Z. Li, James B. Munro, Pei-Yong Shi, Kuang Shen, Jeremy Luban
bioRxiv 2023.03.30.535005; doi: https://doi.org/10.1101/2023.03.30.535005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4397)
  • Biochemistry (9629)
  • Bioengineering (7123)
  • Bioinformatics (24937)
  • Biophysics (12670)
  • Cancer Biology (9994)
  • Cell Biology (14400)
  • Clinical Trials (138)
  • Developmental Biology (7989)
  • Ecology (12147)
  • Epidemiology (2067)
  • Evolutionary Biology (16025)
  • Genetics (10951)
  • Genomics (14778)
  • Immunology (9905)
  • Microbiology (23739)
  • Molecular Biology (9506)
  • Neuroscience (51049)
  • Paleontology (370)
  • Pathology (1545)
  • Pharmacology and Toxicology (2692)
  • Physiology (4038)
  • Plant Biology (8693)
  • Scientific Communication and Education (1512)
  • Synthetic Biology (2404)
  • Systems Biology (6458)
  • Zoology (1350)